Malik Bandealy works in the field of Hematology. He went to medical school at Indiana University School of Medicine. Indiana University School of Medicine is ranked 45 in research and 47 in primary care medicine He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Malik Bandealy is a published MD. He has 2 papers published. The most current publication "Prospective randomized trial of 5-fluorouracil versus 5-fluorouracil plus levamisole in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial." He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1568453298 | |
NPPES Provider LastName | BANDEALY | |
NPPES Provider FirstName | MALIK | |
NPPES Provider ZIPCode | 531427884 | |
NPPES Provider State | WI | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 2350.0 | |
Distinct Opioid Count | 7.0 | |
Opioid Claim Count | 294.0 | |
Percent Opioid Claims | 12.51 |
National Provider Identifier [NPI] | 1568453298 |
Last Name Of The Provider | BANDEALY |
First Name Of The Provider | MALIK |
View All |
![]() |
Dr. David A. Knight, MD
![]() |
![]() |
Dr. Syed Haider, MD
![]() |
![]() |
Dr. Syed S. Haider, MD
![]() |
![]() |
Dr. Raymond W. Knight, MD
![]() |